Results 31 to 40 of about 15,605 (226)

Complex Gastroesophageal Reflux Disease

open access: yesGastro Hep Advances, 2022
Gastroesophageal reflux disease (GERD) is the most prevalent gastrointestinal disorder posing diagnostic and therapeutic challenges. Diagnosis should be objectively defined with endoscopy and pH testing, while novel metrics may augment diagnosis for ...
Diana L. Snyder, David A. Katzka
doaj   +1 more source

Personalized diagnosis of patients with gastroesophageal reflux disease using 24-hour pH-impedance testing and high-resolution esophageal manometry [PDF]

open access: yesТерапевтический архив
Aim. To determine the phenotypic variants of patients with symptoms of gastroesophageal reflux disease (GERD), non-erosive reflux disease (NERD), hypersensitive esophagus (HSE), functional heartburn (FH) using 24-hour pH-impedance testing and high ...
Igor V. Maev   +5 more
doaj   +1 more source

Foregut microbiome in development of esophageal adenocarcinoma [PDF]

open access: yes, 2010
Esophageal adenocarcinoma (EA), the type of cancer linked to heartburn due to gastroesophageal reflux diseases (GERD), has increased six fold in the past 30 years. This cannot currently be explained by the usual environmental or by host genetic factors.
Aaron Tenney   +27 more
core   +2 more sources

Iodine and pregnancy – a qualitative study focusing on dietary guidance and information [PDF]

open access: yes, 2018
Iodine is essential for thyroid hormones synthesis and normal neurodevelopment; however, ~60% of pregnant women do not meet the WHO (World Health Organization) recommended intake.
Bouga, Maria   +2 more
core   +2 more sources

Gastrointestinal functional disorders can benefit from the use of medical devices made of substances

open access: yesFrontiers in Drug Safety and Regulation, 2023
Medical devices made of substances (MDMS) have recently gained great popularity in several specialties of internal medicine, including gastroenterology. In the last decades this discipline has known relevant advances in the cure of severe diseases, such ...
Vincenzo Savarino   +6 more
doaj   +1 more source

SPECIFIC DYSPEPTIC SYMPTOMS ARE ASSOCIATED WITH POOR RESPONSE TO THERAPY IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE [PDF]

open access: yes, 2017
Background: In gastroesophageal reflux disease (GORD) patients, coexistence of functional dyspepsia (FD) is known to be associated with poor response to proton pump inhibitors (PPIs), but the contribution of specific dyspepsia symptoms has not been ...
ANDREOZZI, PAOLO   +9 more
core   +1 more source

Recent Advances and the Potential for Clinical Use of Autofluorescence Detection of Extra-Ophthalmic Tissues [PDF]

open access: yes, 2020
The autofluorescence (AF) characteristics of endogenous fluorophores allow the label-free assessment and visualization of cells and tissues of the human body.
Aigner, Felix   +7 more
core   +1 more source

Current advances in the diagnosis and management of gastroesophageal reflux disease

open access: yesTzu Chi Medical Journal, 2022
Gastroesophageal reflux disease (GERD) is very common and defined as troublesome symptoms owing to excessive acid reflux. The spectrum of GERD is broad, including not only erosive esophagitis and Barrett's esophagus but also nonerosive reflux disease ...
Shu-Wei Liang   +8 more
doaj   +1 more source

Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn [PDF]

open access: yesAlimentary Pharmacology & Therapeutics, 2013
Proton pump inhibitor (PPI)-refractory heartburn may be due to persistent gastro-oesophageal reflux, oesophageal hypersensitivity or functional heartburn (FH). The differentiation between non-erosive reflux disease (NERD) and FH may be very difficult. However, this differentiation is important for appropriate therapeutic management.
A, Kandulski   +6 more
openaire   +2 more sources

Gastrointestinal Symptoms in Marfan Syndrome and Hypermobile Ehlers-Danlos Syndrome. [PDF]

open access: yes, 2018
Objective: Marfan syndrome (MS) is a multisystem disorder caused by a mutation in FBN1 gene. It shares some phenotypic features with hypermobile Ehlers-Danlos syndrome (EDS) such as joint hypermobility.
Child, A   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy